Management of uterine hyperstimulation after prostaglandin E2 administration.
Recent literature suggests that intravaginal or intracervical application of prostaglandin E2 gel may be an effective agent for cervical ripening. One potentially disastrous reported side effect is uterine hyperstimulation. This case report represents the first description of the successful management of uterine hyperstimulation with intravenous ritodrine therapy after the intravaginal administration of prostaglandin E2.
D000282:Administration, Intravaginal; D000328:Adult; D015232:Dinoprostone; D005260:Female; D006340:Heart Rate, Fetal / Q000187:drug effects; D006801:Humans; D007751:Labor, Induced; D008508:Medication Errors; D011247:Pregnancy; D011458:Prostaglandins E / Q000008:administration & dosage / Q000009:adverse effects*; D012312:Ritodrine / Q000627:therapeutic use*; D014590:Uterine Contraction / Q000187:drug effects*
D011458:Prostaglandins E; D012312:Ritodrine; D015232:Dinoprostone